Nevirapine-induced Stevens Johnson-syndrome and fulminant hepatic failure requiring liver transplantation

American Journal of Transplantation

Volumn 10, Issue 7, 2010, Pages 1713-1716

  Jao, J ^a   Sturdevant, M ^a   Del Rio Martin, J ^a   Schiano, T ^a   Fiel, M I ^a   Huprikar, S ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

Hepatotoxicity; liver; nevirapine; Stevens Johnson syndrome; transplant

Indexed keywords

EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CREATININE; HEMOGLOBIN; HYPERTENSIVE FACTOR; PREDNISONE; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LIVER TRANSPLANTATION; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME; BACTEREMIA; BLISTER; BRAIN DISEASE; CD4 LYMPHOCYTE COUNT; CHILL; CHOLESTASIS; DEBRIDEMENT; DISEASE DURATION; DRUG SUBSTITUTION; ENTEROBACTER CLOACAE; EXPLANT; FATIGUE; FEVER; FULMINANT HEPATIC FAILURE; GRAFT DYSFUNCTION; GRAFT FAILURE; HEALTH CARE PERSONNEL; HEMOFILTRATION; HEPATOJEJUNOSTOMY; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIMB; LIP; LIVER CELL; LIVER HEMATOMA; LIVER NECROSIS; LIVER WEIGHT; MALAISE; PHYSICAL EXAMINATION; PSEUDOMONAS INFECTION; RASH; REOPERATION; ROUX Y ANASTOMOSIS; SKIN EXFOLIATION; THROMBOCYTE COUNT; TOXIC HEPATITIS; TREATMENT DURATION; TRUNK; VESICULAR RASH; VIRUS LOAD; ACUTE LIVER FAILURE; CHEMICALLY INDUCED DISORDER; METHODOLOGY; MIDDLE AGED;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEMOFILTRATION; HIV INFECTIONS; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MIDDLE AGED; NEVIRAPINE; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME;

EID: 79958048641     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03153.x     Document Type: Article

References (15)

1. Viramune (nevirapine) Dear Healthcare Professional Letter Nov 2000. In : Roxane Laboratories BIP, Inc, editor. Columbus 2000.
2. Sha BE, Proia LA, Kessler HA. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA 2000 284 : 2772 2773.
3. Patel SM, Johnson S, Belknap SM, Chan J, Sha BE, Bennett C. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr 2004 35 : 120 125.
4. Prakash M, Poreddy V, Tiyyagura L, Bonacini M. Jaundice and hepatocellular damage associated with nevirapine therapy. Am J Gastroenterol 2001 96 : 1571 1574.
5. Buyse S, Vibert E, Sebagh M et al. Liver transplantation for fulminant hepatitis related to nevirapine therapy. Liver Transpl 2006 12 : 1880 1882.
6. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures-worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep 2001 49 : 1153 1156.
7. Johnson S, Baraboutis JG. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA 2000 284 : 2722 2723.
8. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001 15 : 1843 1848.
9. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections. Hepatology 2002 35 : 182 189.
10. Martinez E, Blanco JL, Arnaiz JA et al. Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS 2001 15 : 1261 1268.
11. Sanne I, Mommeja-Marin H, Hinkle J et al. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. J Infect Dis 2005 191 : 825 829.
12. Stern JO, Robinson PA, Love J, Lanes S, Imperiale MS, Mayers DL. A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients. J Acquir Immune Defic Syndr 2003 34 (Suppl 1 S21 S33.
13. Dieterich DT, Robinson PA, Love J, Stern JO. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2004 38 (Suppl 2 S80 S89.
14. Claes P, Wintzen M, Allard S, Simons P, De Coninck A, Lacor P. Eur J Intern Med 2004 4 : 255 258.
15. Huprikar S. Solid organ transplantation in HIV-infected individuals: An update. Rev Med Virol 2009 19 : 317 323.